Skip to Main Content

Paper Details

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
New England Journal of Medicine
225
2022
Circulating Tumor DNA, Patients, Stage II Colon Cancer, circulating tumor DNA, colon cancer, ctDNA, fluoropyrimidine, oxaliplatin, patients, stage II, stage II colon cancer
Author NameAffiliation
Nickolas PapadopoulosWalter and Eliza Hall Institute of Medical Research (J.T., Peter MacCallum Cancer Centre (J.T., University of Melbourne (J.T., the Eastern Health Clinical School, Monash University (R.W., St. Vincent's Hospital (S.-A.M.), Melanoma Institute Australia, University of Sydney, Fiona Stanley Hospital, and Edith Cowan University, Royal Brisbane and Women's Hospital, and the University of Queensland, Newcastle Private Hospital (J.L.), Calvary Mater Newcastle Hospital (F.D.), Royal Hobart Hospital, VIC (T.H.) - all in Australia the Ludwig Center for Cancer Genetics and Therapeutics (J.D.C., Sidney Kimmel Comprehensive Cancer Center (J.D.C., the Sol Goldman Pancreatic Cancer Research Center (J.D.C., Johns Hopkins University School of Medicine, the Howard Hughes Medical Institute (J.P., Johns Hopkins University (J.D.C.), Johns Hopkins Bloomberg School of Public Health (C.T.) - all in Baltimore and the Institute for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University
Kenneth W KinzlerWalter and Eliza Hall Institute of Medical Research (J.T., Peter MacCallum Cancer Centre (J.T., University of Melbourne (J.T., the Eastern Health Clinical School, Monash University (R.W., St. Vincent's Hospital (S.-A.M.), Melanoma Institute Australia, University of Sydney, Fiona Stanley Hospital, and Edith Cowan University, Royal Brisbane and Women's Hospital, and the University of Queensland, Newcastle Private Hospital (J.L.), Calvary Mater Newcastle Hospital (F.D.), Royal Hobart Hospital, VIC (T.H.) - all in Australia the Ludwig Center for Cancer Genetics and Therapeutics (J.D.C., Sidney Kimmel Comprehensive Cancer Center (J.D.C., the Sol Goldman Pancreatic Cancer Research Center (J.D.C., Johns Hopkins University School of Medicine, the Howard Hughes Medical Institute (J.P., Johns Hopkins University (J.D.C.), Johns Hopkins Bloomberg School of Public Health (C.T.) - all in Baltimore and the Institute for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University
Bert VogelsteinWalter and Eliza Hall Institute of Medical Research (J.T., Peter MacCallum Cancer Centre (J.T., University of Melbourne (J.T., the Eastern Health Clinical School, Monash University (R.W., St. Vincent's Hospital (S.-A.M.), Melanoma Institute Australia, University of Sydney, Fiona Stanley Hospital, and Edith Cowan University, Royal Brisbane and Women's Hospital, and the University of Queensland, Newcastle Private Hospital (J.L.), Calvary Mater Newcastle Hospital (F.D.), Royal Hobart Hospital, VIC (T.H.) - all in Australia the Ludwig Center for Cancer Genetics and Therapeutics (J.D.C., Sidney Kimmel Comprehensive Cancer Center (J.D.C., the Sol Goldman Pancreatic Cancer Research Center (J.D.C., Johns Hopkins University School of Medicine, the Howard Hughes Medical Institute (J.P., Johns Hopkins University (J.D.C.), Johns Hopkins Bloomberg School of Public Health (C.T.) - all in Baltimore and the Institute for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University
  • 1 - 3

Datasets